With several oncology biosimilars expected to hit the U.S. market in the next few years, pharmaceutical drug manufacturers need clear insight into stakeholder perceptions and key drivers of adoption in order to thrive in a crowded and complex marketplace.

During this webinar, ZS and industry experts will discuss the following:

  • Current market knowledge and perceptions of biosimilars in therapeutic oncology
  • Experience with existing biosimilars
  • Anticipated adoption of therapeutic biosimilars by physicians, payers and pharmacy directors
  • Drivers and barriers to adoption

Contact us for more insights from ZS’s Biosimilar Adoption Study.

The Advent of Biosimilars in Oncology: Planning Proactively for Change

Home / Insights / Publication

A Panel Discussion with OBR, ZS and Industry Experts on the Changing Roles of Payers, Providers and Manufacturers